Frequent loss of heterozygosity on chromosome 6p in uveal melanoma

Human Immunology

Volumn 60, Issue 10, 1999, Pages 962-969

  Metzelaar Blok, Jessica A W ^a   Jager, Martine J ^a   Moghaddam, Payman Hanifi ^a   Van Der Slik, Arno R ^a   Giphart, Marius J ^a  

^a LEIDEN UNIVERSITY MEDICAL CENTER   (Netherlands)

Author keywords

Chromosome 6p; HLA class I expression; Loss of heterozygosity; Microsatellite markers; Uveal melanoma

Indexed keywords

FORMALDEHYDE; HLA A ANTIGEN; HLA ANTIGEN CLASS 1; HLA B ANTIGEN; MICROSATELLITE DNA; PARAFFIN;

ADULT; AGED; ANTIGEN EXPRESSION; ARTICLE; CHROMOSOME 6P; CLINICAL ARTICLE; CONTROLLED STUDY; EMBEDDING; GENE LOCUS; HETEROZYGOSITY LOSS; HUMAN; HUMAN TISSUE; MOLECULAR GENETICS; PRIORITY JOURNAL; TISSUE FIXATION; UVEA MELANOMA;

CHOROID NEOPLASMS; CHROMOSOMES, HUMAN, PAIR 6; CILIARY BODY; EYE ENUCLEATION; HLA-A ANTIGENS; HLA-B ANTIGENS; HUMANS; LOSS OF HETEROZYGOSITY; MELANOMA; MICROSATELLITE REPEATS; POLYMERASE CHAIN REACTION; UVEAL NEOPLASMS;

EID: 0032745959     PISSN: 01988859     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0198-8859(99)00067-1     Document Type: Article

References (27)

1. Østerlind A. Trends in incidence of ocular malignant melanoma in Denmark 1943-1982. Int J Cancer. 40:1987;161.
2. Rajpal S., Moore R., Karakousis C.P. Survival in metastatic ocular melanoma. Cancer. 52:1983;334.
3. Diener-West M., Hawkins B.S., Markowitz J.A., Schachat A.P. A review of mortality from choroidal melanoma II. A meta-analysis of 5 year mortality rates following enucleation, 1966 through 1988. Arch Ophthalmol. 110:1992;245.
4. Seddon J.M., Albert D.M., Lavin P.T., Robinson N. A prognostic factor study of disease free interval and survival following enucleation for uveal melanoma. Arch Ophthalmol. 101:1983;1894.
5. Kath R., Hayungs J., Bornfeld N., Sauerwein W., Hoffken K., Seeber S. Prognosis and treatment of disseminated uveal melanoma. Cancer. 72:1993;2219.
6. Egan K.M., Seddon J.M., Glynn R., Gragoudas E.S., Albert D.M. Epidemiologic aspects of uveal melanoma. Surv Ophthalmol. 32:1988;239.
7. Heim S., Mitelman F. Primary chromosome abnormalities in human neoplasia. Adv Cancer Res. 52:1989;1.
8. Lasko D., Cavenee W., Nordenskjöld M. Loss of constitutional heterozygosity in human cancer. Ann Rev Genet. 25:1991;281.
9. Singh A.D., Donoso L.A. Genetic aspects of uveal melanoma. Int Ophthalmol Clin. 33:1993;47.
10. Prescher G., Bornfeld N., Hirche H., Horsthemke B., Jockel K.-H., Becher R. Prognostic implications of monosomy 3 in uveal melanoma. Lancet. 347:1996;1222.
11. Sisley K., Rennie I.G., Parsons M.A., Jaques R., Hammond D.W., Bell S.M., et al. Abnormalities of chromosomes 3 and 8, posterior uveal melanoma, a significant association with prognosis. Genes Chromosomes Cancer. 18:1997;1.
12. White V.A., Chambers J.D., Courtright P.D., Chang W.Y., Horsman D.E. Correlation of cytogenetic abnormalities with the outcome of patients with uveal melanoma. Cancer. 83:1998;354.
13. Blom D.J.R., Luyten G.P.M., Mooy C., Kerkvliet S., Zwinderman A.H., Jager M.J. Human leukocyte antigen class I expression marker of poor prognosis in uveal melanoma . Invest Ophthalmol Vis Sci. 38:1997;1865.
14. Cohen E.P., Kim T.S. Neoplastic cells that express low levels of MHC Class I determinants escape host immunity. Sem Cancer Biol. 5:1994;419.
15. Ferrone S., Marincola F.M. Loss of HLA Class I antigens by melanoma cells molecular mechanisms, functional significance and clinical relevance . Immunol Today. 16:1995;487.
16. de Nooij-van Dalen A.G., van Buuren-van Seggelen V.H.A., Mulder A., Gelsthorpe K., Cole J., Lohman P.H.M., Giphart-Gassler M. Isolation and molecular characterization of spontaneous mutants of lymphoblastoid cells with extended loss of heterozygosity. Mutation Res. 374:1997;51.
17. Kisseljoy F., Semionova L., Samoylova E., Mazurenko N., Komissarova E., Zourbitskaya V., Gritzko T., Kozachenko V., Netchushkin M., Petrov S., Smirnov A., Alonso A. Instability of chromosome 6 microsatellite repeats in human cervical tumors carrying papilloma virus sequences. Int J Cancer. 69:1996;484.
18. Rader J.S., Gerhard D.S., O'Sullivan M.I., Li Y., Li L., Liapis H., Huettner P.C. Cervical intraepithelial neoplasia III shows frequent allelic loss in 3p and 6p. Genes Chromosomes & Cancer. 22:1998;57.
19. Merlo A., Gabrielson E., Mabry M., Vollmer R., Baylin S.B., Sidransky D. Homozygous deletion on chromosome 9p and loss of heterozygosity on 9q, 6p, and 6q in primary human small cell lung cancer. Cancer Res. 54:1994;2322.
20. Saitoh Y., Bruner J.M., Levin V.A., Kyritsis A.P. Identification of allelic loss on chromosome arm 6p in human astrocytomas by arbitrarily primed polymerase chain reaction. Genes Chromosomes & Cancer. 22:1998;165.
21. Gruis N.A., Abeln E.C.A., Bardoel A.F.J., Devilee P., Frants R.R., Cornelisse C.J. PCR-based microsatellite polymorphisms in the detection of loss of heterozygosity in fresh and archival tumor tissue. Br J Cancer. 68:1993;308.
22. Dib C., Fauré S., Fizames C., Samson D., Drouot N., Vignal A., Millasseau P., Marc S., Hazan J., Seboun E., Lathrop M., Gyapay G., Morissete J., Weissenbach J. A comprehensive genetic map of the human genome based on 5 264 microsatellites . Nature. 380:1996;152.
23. Foissac A., Crouau-Roy B., Cambon-Thomsen A., Thomsen M. Microsatellites in the HLA region an overview . Tissue Antigens. 49:1997;197.
24. Don R.H., Wainwright B.J., Bakker K., Mattick J.S. 'Touchdown' PCR to circumvent spurious priming during gene amplification. Nucleic Acid Research. 19:1991;4008.
25. Blom D.J.R., Mooy C.M., Luyten G.P.M., Kerkvliet S., Ouwerkerk I., Zwinderman A.H., Schrier P.I., Jager M.J. Inverse correlation between expression of HLA-B and c-myc in uveal melanoma. J Pathol. 181:1997;75.
26. Ma D., Niederkorn J.Y. Transforming growth factor-β down-regulates major histocompatibility complex class I antigen expression and increases the susceptibility of uveal melanoma cells to natural killer cell mediated cytolysis. Immunology. 86:1995;263.
27. Ma D., Luyten G.P.M., Luider T.M., Niederkorn J.Y. Relationship between natural killer cell susceptibility and metastasis of human uveal melanoma cells in a murine model. Invest Ophthalmol Vis Sci. 36:1995;435.